Hase Niklas E, Passarelli Joshua, Robichaud Sabrina, Segalini Nicole, Ganguli Sangrag, Song Cherilyn, Rabinowitz Judy, Aziz Hassan
Department of Surgery, Tufts University School of Medicine, Boston, MA.
Department of Surgery, The George Washington University School of Medicine and Health Sciences, Washington, DC.
Surgery. 2022 Nov;172(5):1429-1433. doi: 10.1016/j.surg.2022.08.013. Epub 2022 Sep 10.
The use of robotics in hepatobiliary and pancreatic surgery has increased. With this increased collaboration, there has also been a push toward improving the transparency of conflicts of interest in terms of funding provided by robotics companies.
Studies with ≥1 American author published between 2016 and 2020 discussing robotic hepatobiliary and pancreatic surgery were included in the analysis. The Centers for Medicare and Medicaid Services Open Payments Program was used to evaluate the accuracy of industry payment disclosures. Conflict of interest was defined as a lack of disclosure of ≥$100 funding from any robotics company in the United States. The primary outcome of this study was to determine the efficacy of the current standard conflict of interest reporting in surgery.
A total of 355 studies (2,413 authors) were included. Of the studies that received robotics funding (n = 133), 20.3% did not disclose their conflicts of interest, whereas 79.7% had a conflict of interest disclosure. However, most of the disclosures (76.5%) were inaccurate.
The findings of this study require an update in journal policies to ensure the accurate disclosure of conflicts of interest in robotic hepatobiliary and pancreatic surgery studies. Similarly, the investigators should ensure that their disclosures are accurate. Finally, surgeons must be more on top of their relationships with these companies and consider their vulnerability to bias.
机器人技术在肝胆胰外科手术中的应用有所增加。随着这种合作的增加，也有人推动提高机器人公司提供资金方面利益冲突的透明度。
分析纳入了2016年至2020年间发表的、有≥1位美国作者讨论机器人肝胆胰手术的研究。使用医疗保险和医疗补助服务中心的公开支付计划来评估行业支付披露的准确性。利益冲突被定义为未披露来自美国任何机器人公司≥100美元的资金。本研究的主要结果是确定当前手术中标准利益冲突报告的有效性。
共纳入355项研究（2413位作者）。在获得机器人技术资金的研究（n = 133）中，20.3%未披露其利益冲突，而79.7%有利益冲突披露。然而，大多数披露（76.5%）不准确。
本研究结果要求期刊政策进行更新，以确保在机器人肝胆胰手术研究中准确披露利益冲突。同样，研究人员应确保其披露准确。最后，外科医生必须更加关注他们与这些公司的关系，并考虑自身易受偏见影响的因素。
